TRINITY BIOTECH
- Shared products
- GLYCATED HEMOGLOBIN (HbA1C), HEMOGLOBINA GLICADA (HbA1C), Instrument intended for immunoassays
- Shared products
- GLYCATED HEMOGLOBIN (HbA1C), HEMOGLOBINA GLICADA (HbA1C), Instrument intended for immunoassays
- Shared products
- GLYCATED HEMOGLOBIN (HbA1C), Instrument intended for immunoassays, Instrumento destinado a imunoensaios
- Shared products
- GLYCATED HEMOGLOBIN (HbA1C), HEMOGLOBINA GLICADA (HbA1C), Instrument intended for immunoassays
- Shared products
- GLYCATED HEMOGLOBIN (HbA1C), Instrument intended for immunoassays, Instrumento destinado a imunoensaios
Explore comprehensive manufacturer profile for TRINITY BIOTECH based in United States through Pure Global AI's free Brazil medical device database. This manufacturer has 7 products registered with ANVISA across 2 unique technical categories. Their regulatory history spans from Aug 10, 2015 to Mar 25, 2019.
This page provides detailed insights including 5 recent product registrations including GLYCATED HEMOGLOBIN (HbA1C), 2 most popular products with GLYCATED HEMOGLOBIN (HbA1C) having 6 registrations, 1 registration holders including TRINITY BIOTECH DO BRASIL COMÉRCIO E IMPORTAÇÃO LTDA., and 5 key competitors with GETEIN BIOTECH, INC. sharing 3 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.